老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

8.63
-0.4400-4.85%
盘后：8.630.00000.00%19:30 EDT
成交量：15.14万
成交额：131.40万
市值：3.01亿
市盈率：-8.82
高：9.08
开：9.08
低：8.51
收：9.07
52周最高：16.76
52周最低：8.51
股本：3,488.27万
流通股本：1,845.34万
量比：0.83
换手率：0.82%
股息：- -
股息率：- -
每股收益(TTM):-0.9783
每股收益(LYR):-0.9800
净资产收益率：-33.21%
总资产收益率：-22.67%
市净率：1.70
市盈率(LYR):-8.81

数据加载中...

总览公司新闻资讯公告
2020/12/15

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/03

重要事件披露

8-K - Current report
2020/10/27

重要事件披露

8-K - Current report
2020/10/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/06

重要事件披露

8-K - Current report
2020/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/01

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/23

重要事件披露

8-K - Current report
2020/09/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/19

重要事件披露

8-K/A [Amend] - Current report
2020/08/18

重要事件披露

8-K - Current report
2020/08/14

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/06/05

重要事件披露

8-K - Current report
2020/04/15

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/03

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多